Oxford Immunotec Global PLC (NASDAQ:OXFD) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a report released on Saturday. The brokerage currently has a $16.00 price objective on the stock. Zacks Investment Research’s price target points to a potential upside of 14.70% from the company’s current price. According to […]
